Magic Hour
SoCal Gas
You are here:  Home  >  Biotech  >  Current Article

MannKind doubles third quarter revenue, trims loss

By   /   Wednesday, November 6th, 2019  /   Comments Off on MannKind doubles third quarter revenue, trims loss

    Print       Email
MannKind, the Westlake Village-based drug delivery platform, said Nov. 6 that revenue jumped 227 percent to $14.6 million for the third quarter as its loss narrowed to $10.4 million from $24 million a year earlier. The company said it earned $6.4 million in revenue for its core Afrezza insulin drug, including its first sales to…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Thousand Oaks approves Caruso apartment complex at The Lakes

Read More →